Therapeutic Targeting of Lewisy and Lewisb with a Novel Monoclonal Antibody 692/29
Figure 5
Binding of 692/29, BR96 and 2-25 LE to normal tissues.
692/29, BR96 and 2-25 LE were assessed for normal tissue binding by IHC. Normal staining to placenta, oesophagus, rectum, gallbladder, bladder, ileum, spleen, jejunum, stomach, breast, kidney, thymus, lung, colon, tonsil, pancreas and duodenum are represented for 692/29 (A), BR96 (B) and 2-25 LE (C).